FRCA Notes


Endovascular Aneurysm Repair (EVAR)


  • EVAR excludes the aneurysm sac from the circulation using a stent graft deployed from within the artery, avoiding laparotomy and aortic cross-clamping
  • It can be used for elective repair of abdominal or thoracic ('TEVAR') aneurysms, and for the emergency management of ruptured AAA
  • The choice between EVAR and open repair is made in the MDT based on anatomy, fitness, life expectancy and patient preference (see AAA background)

Standard (infra-renal) EVAR

  • The femoral arteries are accessed, either percutaneously (ultrasound-guided) or by surgical cut-down
    • Brachial or subclavian access is occasionally needed; this should be discussed before choosing the side for the arterial line
  • A bifurcated stent graft is passed into the aorta under fluoroscopic guidance and deployed across the aneurysm, with limbs extending into the iliac arteries
  • Blood flow into the sac is prevented, and the excluded sac eventually thromboses

  • Anatomical suitability is assessed with CT angiography; key features are:
    • The proximal neck: length, diameter, angulation and thrombus, as this is the 'landing zone' for the seal
    • The distal landing zones in the iliac arteries
    • The calibre and tortuosity of the access vessels
  • Use of a graft outside the manufacturer's instructions for use is not recommended in the elective setting

Complex EVAR

  • Juxta- and supra-renal aneurysms require fenestrated ('FEVAR') or branched grafts with openings for the coeliac, superior mesenteric and renal arteries
    • These are custom-made following 3D reconstruction of CT angiography, which takes several weeks, so are only suitable for elective cases
    • 'Chimney' or parallel grafts are an alternative in more urgent cases
  • Complex grafts mean longer procedures, more fluoroscopy and higher doses of iodinated contrast, with greater blood loss and risk of AKI and spinal cord ischaemia
  • Carbon dioxide can be used as a contrast agent in renal impairment, though it carries a risk of gas embolism, poorer images and a higher radiation dose


Advantages Disadvantages
Less haemodynamic and metabolic disturbance; no cross-clamp Lifelong imaging surveillance (ultrasound or CT)
Reduced blood loss and transfusion More long-term complications (e.g. endoleak, graft migration) and re-intervention
Avoids laparotomy and its short- and long-term complications Early survival advantage is lost in the long term (EVAR 1)
Less pain; can be performed under local or regional anaesthesia Contrast and radiation exposure
Shorter ICU and hospital stay Anatomical constraints; not all aneurysms are suitable
Lower 30-day mortality (EVAR 1) Potential conversion to open repair (and GA) in a patient deemed high-risk

Key trials

  • EVAR 1 randomised patients fit for open repair:
    • 30-day mortality was around a third of that of open repair (1.7% vs. 4.7%)
    • This early survival advantage was lost within a few years; beyond 8 years open repair had lower all-cause and aneurysm-related mortality, the latter largely due to late rupture after EVAR
    • Re-intervention rates were higher after EVAR
  • EVAR 2 randomised patients unfit for open repair to EVAR or no intervention, and found no long-term all-cause survival benefit from EVAR, with a considerable (~9%) 30-day mortality
  • Newer generation stent grafts appear to have lower re-intervention and late rupture rates than those used in the original trials

  • Pre-operative assessment and optimisation is as for open repair, as these patients have a high burden of cardiorespiratory disease (70% have coronary artery disease) and there is always a risk of conversion
  • According to the ACC/AHA guidelines (2007), infra-renal EVAR is an intermediate-risk procedure and complex EVAR a high-risk procedure

EVAR-specific considerations

  • Renal function: these patients are at high risk of AKI from contrast, embolism and stents across the renal arteries
    • Ensure adequate hydration; pre-procedural volume expansion with 0.9% saline or isotonic sodium bicarbonate in those at risk
    • Stop nephrotoxic drugs (e.g. NSAIDs), and plan to limit the contrast dose
    • See renal protection strategies
  • Antiplatelets: EVAR can be performed on dual antiplatelet therapy if it cannot be postponed (e.g. after recent PCI)
  • Ability to lie flat and still for the duration of the procedure, and to perform breath-holds, if an awake technique is planned
  • High-risk complex cases may need a pre-operative CSF drain (see spinal cord protection)

Location

  • EVAR should be carried out in a hybrid theatre; combining high-quality imaging with the ability to convert to an open procedure
  • If this is in IR or outside the main theatre complex, the challenges of remote anaesthesia apply
  • Radiation protection: lead gowns, mobile shielding and distance from the X-ray source
  • Access to the patient is limited by imaging equipment, so long monitoring cables and IV extensions are needed

Monitoring and access

  • AAGBI monitoring plus an arterial line, ideally before induction, on the side contralateral to any planned upper limb access
  • Large-bore IV access, as conversion or vessel injury can cause major haemorrhage
  • Central venous access and cardiac output monitoring for complex or prolonged procedures
  • Temperature and hourly urine output
  • Cell salvage and a rapid infuser should be available for complex cases

Anaesthetic technique

  • GA, neuraxial and local anaesthesia (± sedation) are all acceptable; there is no robust evidence of a morbidity or mortality benefit of one over another
    • The ESVS (2024) suggest locoregional anaesthesia may be considered in preference to GA for elective EVAR
  • The choice depends on patient comorbidity and preference, anticoagulant or antiplatelet drugs, ability to lie flat and still, and anticipated duration

  • Awake techniques: patients may become restless during long procedures, and prolonged femoral or internal iliac occlusion causes leg and buttock ischaemic pain; be ready to convert to GA
  • Neuraxial techniques: intra-operative heparin is not a contraindication, but the timing of epidural catheter removal needs careful consideration
  • GA: brief periods of apnoea are needed for digital subtraction angiography, so controlled ventilation is preferable

Anticoagulation and blood loss

  • IV heparin (50 - 100 IU/kg) is given once the access vessels are cannulated, ± ACT monitoring (target ~2 - 2.5× baseline) and protamine reversal at the end
  • Prophylactic antibiotics should be given
  • Blood loss in simple infra-renal EVAR is ~200ml, and transfusion is rare
    • An unexpected fall in BP or transfusion requirement should prompt a search for occult bleeding, e.g. retroperitoneal from an access vessel, with a low threshold for angiography
    • The highest-risk period for aortic rupture is during stent deployment

Intra-operative complications

  • Failed deployment and conversion to open repair (~2%), more common in women and smaller patients
  • Arterial rupture or dissection
  • Atheroembolism
  • Inadvertent coverage of renal or mesenteric arteries
  • Ischaemia of the bowel, kidneys, buttocks or legs

  • Most simple EVAR patients can return to a ward; high-risk patients and complex EVAR should go to a critical care area
  • Monitor renal function, lower limb perfusion and neurology
  • Continue statin, antiplatelet and blood pressure therapy indefinitely

Early complications

  • Access site bleeding, haematoma, pseudoaneurysm or arterial occlusion
  • Limb ischaemia from graft limb kinking or occlusion, or embolism
  • AKI
  • Spinal cord ischaemia
    • Rare after infra-renal EVAR (0.21%), but higher with complex EVAR and TEVAR as longer grafts cover more segmental arteries
    • Maintain a high index of suspicion and insert a spinal drain if new neurology develops (see spinal cord protection)
  • Post-implantation syndrome (30 - 40%)
    • A self-limiting, non-infectious inflammatory response with fever and raised white cell count and CRP

Long-term complications

  • Endoleak; persistent blood flow into the aneurysm sac, and the most common reason for re-intervention (needed in 10 - 30%)
Type Source Significance
I Graft attachment site; proximal (Ia) or distal (Ib) High-pressure; needs prompt treatment
II Retrograde flow from branch vessels e.g. lumbar or inferior mesenteric arteries Most common; often managed with surveillance
III Graft defect or junctional separation High-pressure; needs prompt treatment
IV Graft wall porosity Usually self-limiting
V 'Endotension'; sac expansion without a visible leak May need re-intervention if sac grows

  • Graft migration
  • Graft infection
  • Delayed sac rupture
  • These are why lifelong imaging surveillance is required after EVAR

Previous: Aortic cross-clamp physiology  |  Next: Elective open repair